Gland Pharma IPO Subscription Status
Gland Pharma IPO was subscribed 2.06 times when bidding closed on 11 Nov 2020: QIB 6.4x, NII 0.51x, Retail 0.24x.
The Gland Pharma IPO has been subscribed 2.06x times overall. Retail investors have shown interest with bids for 0.24x the shares available. The Non-Institutional Investor (NII) category has been subscribed 0.51x. Qualified Institutional Buyers (QIBs) have subscribed 6.4x. Data last updated on 11 Nov, 06:58 PM.
The IPO subscription period has ended. The issue opened on 09 Nov, 2020 and closes on 11 Nov, 2020. The shares are expected to list on stock exchanges on 20 Nov, 2020.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
Live bidding
Shares bid against shares offered, category by category, as published by the exchanges. Summary splits NII into bHNI (above ₹10 lakh) and sHNI (₹2–10 lakh); switch to Detailed for the exchange's own sub-category rows.
| Category | Bid details | Times |
|---|---|---|
| QIB | - of - - | 6.4x |
| NII | - of - - | 0.51x |
| Retail | - of - - | 0.24x |
| TOTAL | - - | 2.06x |
Gland Pharma IPO allotment probability
Your odds of an allotment in each category at the current subscription.
Odds = allotment slots ÷ applications, or the subscription multiple where counts aren't available. Retail and HNI allotment is by lottery; QIB is proportionate. Not investment advice.
Subscription insights
What the current book is saying, read off the category numbers above.
Retail Allotment
Currently undersubscribed. Retail investors applying now have a high mathematical probability of receiving full allotment.
Institutional Backing
Massive institutional interest with QIBs subscribing 6.4x. This often signals long-term confidence from professional funds.
Day-wise subscription history
End-of-day subscription across the 3-day bidding window. On phones, tap a day for the category split.
| Date | Total | ||
|---|---|---|---|
|
11 Nov 2020
Day 3 |
2.06x | ▼ | |
|
QIB6.4x
BHNI-
SHNI-
Retail0.24x
|
|||
|
10 Nov 2020
Day 2 |
0.22x | ▼ | |
|
QIB0.48x
BHNI-
SHNI-
Retail0.15x
|
|||
|
09 Nov 2020
Day 1 |
0.05x | ▼ | |
|
QIB-
BHNI-
SHNI-
Retail0.08x
|
|||
Gland Pharma IPO dates
From the bidding window to listing. Today is 13 November.
- Open 09 Nov 2020
- Close 11 Nov 2020
- Allotment 17 Nov 2020
- Refund/credit 18 Nov 2020
- Listing 20 Nov 2020
What does this subscription data mean?
IPO subscription data tells you how much demand exists for the shares being offered, broken down by investor category. Understanding each category helps you gauge the real sentiment behind the numbers:
- 01 QIB (Qualified Institutional Buyers) — includes mutual funds, FIIs, insurance companies, and banks. QIBs do deep due diligence before bidding. A QIB subscription above 10x is a strong institutional endorsement. Watch QIB numbers closely on the final day — they often hold back and flood in after 3 PM.
- 02 NII / HNI (Non-Institutional Investors) — high-net-worth individuals bidding above ₹2 lakh. NII allotment is proportionate (not lottery), so higher NII subscription means smaller per-lot allotment. Big HNI (B-HNI) bids above ₹10 lakh; Small HNI (S-HNI) bids ₹2–10 lakh.
- 03 Retail — individual investors bidding up to ₹2 lakh. When retail is below 1x, everyone who applied gets full allotment. When oversubscribed, SEBI mandates a computerised lottery — only 1 lot per successful applicant regardless of how many lots you apply for.
- 04 Overall Subscription — a blended multiple across all categories. A total subscription above 10x is considered strong; above 50x is exceptional and usually predicts strong listing gains.
Data sourced from BSE/NSE. Subscription numbers are updated during bidding hours (10 AM – 5 PM IST) on active subscription days.
Frequently asked
What is the current subscription status of Gland Pharma IPO?
As of IPO close date (11 Nov, 2020), the Gland Pharma IPO is subscribed 2.06x times. Retail category is 0.24x, and NII is 0.51x subscribed.
When is the allotment date for Gland Pharma IPO?
The allotment for Gland Pharma IPO is expected to be finalized on 17 November, 2020.
What is the GMP of Gland Pharma?
The Grey Market Premium (GMP) for Gland Pharma is currently ₹110, indicating a potential listing gain of 7%.
When will Gland Pharma IPO list on the stock market?
Gland Pharma is scheduled to list on BSE and NSE on 20 November, 2020.
What are the chances of getting allotment in Gland Pharma IPO?
The retail category is currently undersubscribed at 0.24x, which means most applicants are likely to receive full allotment. This is a good window to apply if you haven't already.
What does QIB subscription of 6.4x mean for Gland Pharma IPO?
Moderate — QIBs have subscribed 6.4x. Institutional demand is present but not overwhelming. Watch for any last-minute QIB surge on the final day.
How to check Gland Pharma IPO allotment status?
After the allotment date (17 Nov, 2020), you can check your Gland Pharma IPO allotment status on IPO Guru's allotment checker, on the BSE/NSE website using your PAN or application number, or through your broker's app.
Explore Gland Pharma IPO further
Track every stage of this IPO, from subscription to listing.
It has listed — go back to the fundamentals.
Live grey market premium, Kostak and Subject to Sauda, with the day-wise trend.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
Subscription moves by the hour. Get it on your phone.
Live GMP alerts, subscription updates and allotment status for every Mainboard and SME issue — fast, free and secure.
Not investment advice. Subscription figures are as published by BSE/NSE and change until bidding closes.
